We’re delighted to add a summary of a recent speaker event which explored current concepts of treating to target in inflammatory bowel disease and the use of biosimilars.
The presentations were given by Professor Peyrin-Biroulet, Professor of Medicine and Head of the IBD unit at Nancy University Hospital in France, and the discussion was moderated by Dr Lena Thin, a Consultant Gastroenterologist at Fiona Stanley Hospital.
Please login below to download this issue (PDF)